Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Medical Instruments & Supplies

Poly Medicure Limited manufactures and sells medical devices in India and internationally. It offers infusion devices, such as I.V. cannulas, mid line catheters, arterial cannula, three way stop cocks, I.V. infusion sets, manifolds, safety winged infusion sets, T-type extension sets, stylet/mandrin with luer locks, vial access spikes, measured volume fluid administration sets, extension lines, central venous catheters, CVP manometers, needle free connectors, pre filled syringes, vascular accesses, and blood administration sets. The company also provides nasogastric and infant feeding tubes, gastro-duodenal feeding tubes, and umbilical catheters; urine collection bags, foley balloon catheters, irrigation sets, urine drainage catheters, and urine collection bags with measured volume meters; and endotracheal and tracheostomy tubes, mucus extractors, ventilator circuits, bain circuits, catheter mounts, spinal needles, HME filters, and laryngeal mask airways. It offers oncology products; endo bronchial suction catheters, oxygen catheters, respiratory exercisers, nasal oxygen cannulas, oro-pharyngeal airways, variable concentration masks, oxygen mask with reservoirs, fixed concentration masks, and aerosol therapy masks; and dialyzers, blood lines, dialysis systems, fistula needles, haemodialysis catheters, and peritoneal dialysis and transfusion sets. The company provides closed wound suction units, under water seal drainage systems, high pressure vacuum bottles, yankauer suction sets, and thoracic drainage catheters; blood collection tubes, safety blood collection sets, blood collection needles, ESR pipettes, and luer adaptors; blood bag systems; face protective shields, polymasks, and viral transport medium kits; and insulin syringes, sputum collectors, dry brushes, umbilical cord clamps, luer locks, cannula fixators, injection stoppers, luer lock injection sites, universal caps, and ECG electrodes. The company was incorporated in 1995 and is based in New Delhi, India.

Revenue projections:

Revenue projections for POLYMED
Revenue projections for POLYMED

Poly Medicure Limited's projected revenue decline from last year is likely to make investors cautious. Lower revenues often hurt a company's bottom line, leading investors to be concerned about the company's ability to maintain profitability and deliver strong financial results in the future.

Financial Ratios:

currentRatio 5.179000
forwardPE 40.163742
debtToEquity 6.517000
earningsGrowth 0.253000
revenueGrowth 0.166000
grossMargins 0.667820
operatingMargins 0.223290
trailingEps 34.200000
forwardEps 7.680000

Poly Medicure Limited's current ratio of 5.179 highlights the company's solid liquidity, indicating that it can easily service its short-term debt. Poly Medicure Limited's ample cash reserves and current assets ensure that the company is well-positioned to meet its immediate financial liabilities.
With earnings and revenue growth in positive territory, Poly Medicure Limited is projected to expand its business. This strong financial performance suggests the company will continue to grow, as increased profitability and sales drive future success.
POLYMED's positive gross and operating margins indicate strong financial performance. These margins show that the company is profitable and efficient in its operations, with effective cost control contributing to its overall financial success.
POLYMED's forward EPS being lower than its trailing EPS suggests the company is expected to face declining profits. This points to a less favorable financial outlook for the coming year.

Price projections:

Price projections for POLYMED
Price projections for POLYMED

POLYMED's price has consistently hovered around the lower end of analysts' projections. This pattern may reflect concerns regarding the company's ability to achieve its anticipated growth.

Recommendation changes over time:

Recommendations trend for POLYMED
Recommendations trend for POLYMED


The analysts' collective view on POLYMED remains unclear, offering no definitive buy or sell signals. Investors may need to consider a broader range of market indicators and trends to form a more informed opinion on the stock's potential.